Dr. Lal PathLabs Ltd
BSE: 539524
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 675.20+6.8% | 632.10-9.6% | 699.60+9.2% | 640.70+11.0% | 577.20+9.3% | 528.10-9.6% | 583.90 |
| Other Income | 37.00+39.1% | 26.60+16.7% | 22.80-13.3% | 26.30+4.4% | 25.20-14.6% | 29.50+34.1% | 22.00 |
| Total Income | 712.20+8.1% | 658.70-8.8% | 722.40+8.3% | 667.00+10.7% | 602.40+8.0% | 557.60-8.0% | 605.90 |
| EXPENSES | |||||||
| Expenditure | 542.30+7.3% | 505.50-4.2% | 527.60+6.7% | 494.60+8.1% | 457.50+12.6% | 406.40-3.8% | 422.60 |
| Tax | 28.80-7.1% | 31.00-36.9% | 49.10+13.9% | 43.10+1331.4% | -3.50-109.5% | 36.70-23.7% | 48.10 |
| PROFIT | |||||||
| PBT | 169.90+38.0% | 123.10-36.8% | 194.80+13.0% | 172.40+19.0% | 144.90-4.2% | 151.20-17.5% | 183.30 |
| Net Profit | 141.10+53.2% | 92.10-36.8% | 145.70+12.7% | 129.30-12.9% | 148.40+29.6% | 114.50-15.3% | 135.20 |
| KEY METRICS | |||||||
| OPM % | 26.88%+4.16pp | 22.72%-8.03pp | 30.75%+2.13pp | 28.62%+1.06pp | 27.56%+9.00pp | 18.56%-5.09pp | 23.65% |
| NPM % | 19.81%+5.83pp | 13.98%-6.19pp | 20.17%+0.78pp | 19.39%-5.24pp | 24.63%+4.10pp | 20.53%-1.78pp | 22.31% |
| EPS | 8.45+53.1% | 5.52-68.4% | 17.46+12.6% | 15.51-12.9% | 17.80+29.5% | 13.74-15.4% | 16.24 |
Corporate Events
Board MeetingLALPATHLAB
202630Apr
Board Meeting
To consider and approve the Audited (Standalone & Consolidat…
BSE Filing ↗ Board MeetingLALPATHLAB
202630Jan
Board Meeting
Update on board meeting, Consider and approve the Un-audited…
BSE Filing ↗ Board MeetingLALPATHLAB
202423Oct
Board Meeting
Approval Of The Un-Audited (Standalone & Consolidated) Finan…
BSE Filing ↗ Board MeetingLALPATHLAB
202410May
Board Meeting
Consider and approve Audited (Standalone & Consolidated) Fin…
BSE Filing ↗ Board MeetingLALPATHLAB
20241Feb
Board Meeting
Consideration and approval of Un-audited Financial Results f…
BSE Filing ↗ Board MeetingLALPATHLAB
20232Nov
Board Meeting
consider and approve unaudited financial results for the Qua…
BSE Filing ↗